Contact Us
Thank you for your interest. We have completed the 013 Open Label trial enrollment at this time.
For information on the SER-109 Expanded Access Program, please visit https://www.serestherapeutics.com/patients-and-physicians/.
The open-label clinical study of SER-109 is being offered at locations across the United States and Canada. Find a study site near you by entering your ZIP code below.
SER-109 is still being tested and has not been approved by any regulatory authorities, including the U.S. Food and Drug Administration (FDA). It is currently only available through clinical trials. The safety and effectiveness of SER-109 are currently not known.
© 2021 Seres Therapeutics